# STAR Sports Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/star-sports-medicine

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.starsportmed.com
- Latest round: Series B (Jan 1, 2022)
- Investors on record: 3

## About

Based in Beijing, China and founded in 2017, Star Sports Medicine Co., Ltd., trading under the name STAR Sports Medicine and formerly known as Beijing Tianxing Bomaidi Medical Co., Ltd., provides arthroscopic sports medicine solutions for the healthcare industry. The company utilizes technology platforms such as biomaterials, imaging power, smart medical, and tissue engineering to develop its products. The company’s portfolio includes 63 products, including implants, surgical equipment, and regenerative repair products, supported by numerous domestic and international medical device certificates. Prior to going public, the company completed two deals. In May 2026, the company raised approximately HKD 830 million in an IPO on the Hong Kong Exchanges and Clearing Ltd (HKEX) under the ticker "1609".

The company works with hospitals and surgical centers to provide advanced shoulder implants, surgical instruments, and full-cycle clinical sports medicine solutions. The products facilitate minimally invasive surgical procedures for soft tissue injuries across the shoulder, knee, hip, foot, ankle, elbow, hand, and wrist.

The company generates revenue from B2B contracts with healthcare providers globally. Sales involve surgical instruments and implants tailored to specific surgical needs.

The company plans to use the IPO funding to support the development of new products and expand into new geographic markets.

## Funding rounds

- Series B, Jan 1, 2022 — OrbiMed Advisors, Legend Capital, 3W Partners
- Angel, Jul 22, 2020 — Legend Capital

## Investors

- Legend Capital — Angel, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- 3W Partners (https://capitalatlas.ai/funds/3w-partners) — Series B